Regular daily intake of black tea improves oxidative stress biomarkers and decreases serum C-reactive protein levels in type 2 diabetic patients

Annals of Nutrition and Metabolism

Volumn 57, Issue 1, 2010, Pages 40-49

  Neyestani, Tirang R ^a   Shariatzade, Nastaran ^a   Kalayi, Ali ^a   Gharavi, A'Azam ^a   Khalaji, Niloufar ^a   Dadkhah, Monireh ^a   Zowghi, Telma ^a   Haidari, Homa ^a   Shab Bidar, Sakineh ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Black tea; Oxidative stress; Type 2 diabetes

Indexed keywords

BLACK TEA EXTRACT; C REACTIVE PROTEIN; GLUTATHIONE;

ANTHROPOMETRY; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; DOSE RESPONSE; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE;

ANTIOXIDANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAMELLIA SINENSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PLANT EXTRACTS; TEA;

CAMELLIA SINENSIS;

EID: 77954906980     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000312666     Document Type: Article

References (75)

1. Powers AC: Diabetes mellitus; in Kasper DLBE, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds): Harrison's Principles of Internal Medicine, ed 16. New York, McGraw-Hill, 2005, pp 2152-2180.
2. Craig ME, Hattersley A, Donaghue KC: Definition, epidemiology and classification of diabetes in children and adolescents. Pediatr Diabetes 2009; 10 (suppl 12): 3-12.
3. Thomas JE, Foody JM: The pathophysiology of cardiovascular disease in diabetes melli-tus and the future of therapy. J Cardiometab Syndr 2007; 2:108-113.
4. Nanda N, Bobby Z, Hamide A: Oxidative stress and protein glycation in primary hy-pothyroidism: male/female difference. Clin Exp Med 2008; 8:101-108.
5. Safciuc F, Constantin A, Manea A, Nicolae M, Popov D, Raicu M, Alexandru D, Con-stantinescu E: Advanced glycation end products, oxidative stress and metalloproteinases are altered in the cerebral microvasculature during aging. Curr Neurovasc Res 2007; 4: 228-234.
6. Selvaraj N, Bobby Z, Sridhar MG: Increased glycation of hemoglobin in chronic renal failure: [corrected] potential role of oxidative stress. Arch Med Res 2008; 39:277-284.
7. Stirban A, Negrean M, Gotting C, Uribarri J, Gawlowski T, Stratmann B, Kleesiek K, Koschinsky T, Vlassara H, Tschoepe D: Dietary advanced glycation endproducts and oxidative stress: in vivo effects on endothe-lial function and adipokines. Ann NY Acad Sci 2008; 1126:276-279.
8. Negrean M, Stirban A, Stratmann B, Gaw-lowski T, Horstmann T, Götting C, Kleesiek K, Mueller-Roesel M, Koschinsky T, Uribar-ri J, Vlassara H, Tschoepe D: Effects of low-and high-advanced glycation endproduct meals on macro-and microvascular endo-thelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 2007; 85:1236-1243.
9. Selvaraj N, Bobby Z, Sridhar MG: Oxidative stress: does it play a role in the genesis of early glycated proteins? Med Hypotheses 2008; 70:265-268.
10. Robertson R, Zhou H, Zhang T, Harmon JS: Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys 2007; 48: 139-146.
11. Mukhtar H, Ahmad N: Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 2000; 71: 1698 S-1702 S ; discussion 1703S-1704S.
12. Lambert JD, Hong J, Yang GY, Liao J, Yang CS: Inhibition of carcinogenesis by poly-phenols: evidence from laboratory investigations. Am J Clin Nutr 2005; 81:284S-291S.
13. Neyestani TR, Gharavi A, Kalayi A: Selective effects of tea extract and its phenolic compounds on human peripheral blood mono-nuclear cell cytokine secretions. Int J Food Sci Nutr 2009; 60(suppl 1):79-88.
14. Neyestani TR, Khalaji N, Gharavi A: Selective microbiologic effects of tea extract on certain antibiotics against Escherichia coli in v itro. J A ltern Complement Med 2007; 13 : 1119-1124.
15. Neyestani TRK, Khalaji N, Gharavi, A: Black and green teas may have selective synergistic or antagonistic effects on certain antibiotics against Streptococcus pyogenes in vitro. J Nutr Environ Med 2007; 16 : 258-266.
16. Kalantari N, Ghafari M: National Comprehensive Study on Household Food Consumption Pattern and Nutritional Status, IR Iran, 2001-2003. Tehran, Shaheed Beheshti Medical University, National Nutrition and Food Technology Research Institute, Department of Nutrition Research, 2005.
17. Sung H, Na h J, Chu n S, Park H, Yang SE, Min WK: In vivo antioxidant effect of green tea. Eur J Clin Nutr 2000; 54:527-529.
18. Rifai N, Warnick GR: Lipids, lipoproteins, apolipoproteins and other cardiovascular risk factors; in Burtis CA AE, Bruns DE (eds): Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4 ed. Philadelphia, W.B. Saunders 2006, pp 948.
19. Matthews DR, Hosker JP, Rudenski AS, Nay-lor BA, Treacher DF, Turner RC: Homeosta-sis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Dia-betologia 1985; 28:412-419.
20. Neyestani TR, Shariatzadeh N, Gharavi A, Kalayi A, Khalaji N: Physiologica l dose of ly-copene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with type 2 diabetes mellitus: a possible role in the prevention of long-term complications. J Endocrinol Invest 2007; 30: 833-838.
21. Neyestani TR, Shariat-Zadeh N, Gharavi A, Kalayi A, Khalaji N: The opposite associations of lycopene and body fat mass with humoral immunity in type 2 diabetes mellitus: a possible role in atherogenesis. Iran J Allergy Asthma Immunol 2007; 6: 79-87.
22. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG: Uric acid and serum anti-oxidant capacity: a reaction to atherosclerosis? Atherosclerosis 2000; 148 : 131-139.
23. Anderson RA, Polansky MM: Tea enhances insulin activity. J Agric Food Chem 2002; 50: 7182-7186.
24. Zhong L, Furne JK, Levitt MD: An extract of black, green, and mulberry teas causes mal-absorption of carbohydrate but not of triac-ylglycerol in healthy volunteers. Am J Clin Nutr 2006; 84:551-555.
25. Wolfram S, Raederstorff D, Preller M, Wang Y, Teixeira SR, Riegger C, Weber P: Epigal-locatechin gallate supplementation alleviates diabetes in rodents. J Nutr 2006; 136: 2512-2518.
26. Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H: Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 2008; 62 : 953-960.
27. Lin JK, Lin-Shiau SY: Mechanisms of hypo-lipidemic and anti-obesity effects of tea and tea polyphenols. Mol Nutr Food Res 2006; 50: 211-217.
28. Davies MJ, Judd JT, Baer DJ, Clevidence BA, Paul DR, Edwards AJ, Wiseman SA, Muesing RA, Chen SC: Black tea consumption reduces total and LDL cholesterol in mildly hyper-cholesterolemic adults. J Nutr 2003; 133: 3298S-3302S.
29. McAnlis GT, McEneny J, Pearce J, Young IS: Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr 1998; 52:202-206.
30. Bingham SA, Vorster H, Jerling JC, Magee E, Mulligan A, Runswick SA, Cummings JH: Effect of black tea drinking on blood lipids, blood pressure and aspects of bowel habit. Br J Nutr 1997; 78:41-55.
31. Riccioni G, Bucciarelli T, Mancini B, Cor-radi F, Di Ilio C, Mattei PA, D'Orazio N: An-tioxidant vitamin supplementation in cardiovascular diseases. Ann Clin Lab Sci 2007; 37: 89-95.
32. Vinson JA, Teufel K, Wu N: Green and black teas inhibit atherosclerosis by lipid, antioxi-dant, and fibrinolytic mechanisms. J Agric Food Chem 2004; 52:3661-3665.
33. Serafini M, Ghiselli A, Ferro-Luzzi A: Red wine, tea, and antioxidants. Lancet 1994; 344: 626.
34. Pedersen CB, Kyle J, Jenkinson AM, Gardner PT, McPhail DB, Duthie GG: Effects of blueberry and cranberry juice consumption on the plasma antioxidant capacity of healthy female volunteers. Eur J Clin Nutr 2000; 54: 405-408.
35. McAnlis GT, McEneny J, Pearce J, Young IS: Absorption and antioxidant effects of quer-cetin from onions, in man. Eur J Clin Nutr 1999; 53: 92-96.
36. Serafini M, Bugianesi R, Salucci M, Azzini E, Raguzzini A, Maiani G: Effect of acute ingestion of fresh and stored lettuce (Lactuca sa-tiva) on plasma total antioxidant capacity and antioxidant levels in human subjects. Br J Nutr 2002; 88:615-623.
37. Serafini M, Bugianesi R, Maiani G, Valtuena S, De Santis S, Crozier A: Plasma antioxi-dants from chocolate. Nature 2003; 424:1013.
38. Maxwell S, Thorpe G: Tea flavonoids have little short term impact on serum antioxi-dant activity. BMJ 1996; 313:229.
39. Serafini M, Ghiselli A, Ferro-Luzzi A : In vivo antioxidant effect of green and black tea in man. Eur J Clin Nutr 1996; 50:28-32.
40. Neyestani TR, Fereydouni Z, Hejazi S, Sale-hi-Nasab F, Nateghifard F, Maddah M, Karandish M: Vitamin C status in Iranian children with acute lymphoblastic leukemia: evidence for increased utilization. J Pediatr Gastroenterol Nutr 2007; 45:141-144.
41. Young JF, Nielsen SE, Haraldsdottir J, Daneshvar B, Lauridsen ST, Knuthsen P, Crozier A, Sandström B, Dragsted LO: Effect of fruit juice intake on urinary quercetin excretion and biomarkers of antioxidative status. Am J Clin Nutr 1999; 69:87-94.
42. Young JF, Dragstedt LO, Haraldsdottir J, Daneshvar B, Kall MA, Loft S, Nilsson L, Nielsen SE, Mayer B, Skibsted LH, Huynh-Ba T, Hermetter A, Sandström B: Green tea extract only affects markers of oxidative status postprandially: lasting antioxidant effect of f lavonoid-free diet. Br J Nutr 2002; 87: 343-355.
43. Collins AR: Assays for oxidative stress and antioxidant status: applications to research into the biological effectiveness of polyphe-nols. Am J Clin Nutr 2005; 81 : 261S-267S.
44. Serafini M, Del Rio D: Understanding the association between dietary antioxidants, re-dox status and disease: is the Total Antioxi-dant Capacity the right tool? Redox Rep 2004; 9: 145-152.
45. Gardner EJ, Ruxton CH, Leeds AR: Black tea: helpful or harmful? A review of the evidence. Eur J Clin Nutr 2007; 61:3-18.
46. Wang XL, Rainwater DL, VandeBerg JF, Mitchell BD, Mahaney MC: Genetic contributions to plasma total antioxidant activity. 2001: 1190-1195.
47. Fattman CL, Schaefer LM, Oury TD: Extracellular superoxide dismutase in biology and medicine. Free Radic Biol Med 2003; 35: 236-256.
48. Adachi T, Ohta H, Hirano K, Hayashi K, Marklund SL: Non-enzymic glycation of human extracellular superoxide dismutase. Biochem J 1991; 279: 263-267.
49. Adachi T, Nakamura M, Yamada H, Futen-ma A, Kato K, Hirano K: Quantitative and qualitative changes of extracellular-super-oxide dismutase in patients with various diseases. Clin Chim Acta 1994; 229: 123-131.
50. Adachi T, Kodera T, Ohta H, Hayashi K, Hi-rano K: The heparin binding site of human extracellular-superoxide dismutase. Arch Biochem Biophys 1992; 297:155-161.
51. Sentman ML, Jonsson LM, Marklund SL: Enhanced alloxan-induced beta-cell damage and delayed recovery from hyperglycemia in mice lacking extracellular-superoxide dismutase. Free Radic Biol Med 1999; 27:790-796.
52. Yamada H, Adachi T, Fukatsu A, Misao S, Yamada Y, Aoki T, Miura N, Sakuma M, Ni-shikawa K, Futenma A, Kakumu S: Extracellular superoxide dismutase and glomerular mesangial cells: its production and regulation. FEBS Lett 2002; 519 : 77-81.
53. Yamada H, Yamada Y, Adachi T, Fukatsu A, Sakuma M, Futenma A, Kakumu S: Protective role of extracellular superoxide dis-mutase in hemodialysis patients. Nephron 2000; 84:218-223.
54. Marikovsky M, Ziv V, Nevo N, Harris-Cerruti C, Mahler O: Cu/Zn superoxide dis-mutase plays important role in immune response. J Immunol 2003; 170 : 2993-3001.
55. van het Hof KH, de Boer HS, Wiseman SA, Lien N, Westrate JA, Tijburg LB: Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr 1997;66:1125-1132.
56. Jones DP, Mody VC Jr, Carlson JL, Lynn MJ, Sternberg P Jr: Redox analysis of human plasma allows separation of pro-oxidant events of aging from decline in antioxidant defenses. Free Radic Biol Med 2002; 33:1290-1300.
57. Moriarty SE, Shah JH, Lynn M, Jiang S, Openo K, Jones DP, Sternberg P: Oxidation of glutathione and cysteine in human plasma associated with smoking. Free Radic Biol Med 2003; 35: 1582-1588.
58. Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg P Jr, Reed RL, Jones DP: Glutathione in human plasma: decline in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med 1998; 24:699-704.
59. Borras C, Gambini J, Vina J: Mitochondrial oxidant generation is involved in determining why females live longer than males. Front Biosci 2007; 12:1008-1013.
60. Vina J, Lloret A, Valles SL, Borrás C, Badía MC, Pallardó FV, Sastre J, Alonso MD: Effect of gender on mitochondrial toxicity of Alzheimer's Abeta peptide. Antioxid Redox Signal 2007; 9: 1677-1690.
61. Vina J, Borras C, Miquel J: Theories of ageing. IUBMB Life 2007; 59: 249-254.
62. Vina J, Borras C, Gambini J, Sastre J, Pal-lardo FV: Why females live longer than males: control of longevity by sex hormones. Sci Aging Knowledge Environ 2005; 2005:pe17.
63. Borras C, Sastre J, Garcia-Sala D, Lloret A, Pallardo F V, Vina J: Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med 2003; 34: 546-552.
64. Matsumoto RL, Bastos DH, Mendonca S, Nunes VS, Bartchewsky W, Ribeiro ML, de Oliveira Carvalho P: Effects of Mate Tea (Ilex paraguariensis) ingestion on mRNA expression of antioxidant enzymes, lipid peroxidation, and total antioxidant status in healthy young women. J Agric Food Chem 2009; 57: 1775-1780.
65. Ross R: Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340:115-126.
66. Koenig W: Inflammation and coronary heart disease: an overview. Cardiol Rev 2001; 9: 31-35.
67. Yumei F, Zhou Y, Zheng S, Chen A: The an-tifibrogenic effect of (-)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells. Lab Invest 2006; 86:697-709.
68. Hung CF, Huang TF, Chiang HS, Wu WB: (-)-Epigallocatechin-3-gallate, a polypheno-lic compound from green tea, inhibits fibro-blast adhesion and migration through multiple mechanisms. J Cell Biochem 2005; 96: 183-197.
69. de Maat MP, Pijl H, Kluft C, Princen HM: Consumption of black and green tea had no effect on inflammation, haemostasis and en-dothelial markers in smoking healthy individuals. Eur J Clin Nutr 2000; 54: 757-763.
70. Hodgson JM, Puddey IB, Mori TA, Burke V, Baker RI, Beilin LJ: Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Eur J Clin Nutr 2001; 55: 881-886.
71. De Bacquer D, Clays E, Delanghe J, De Backer G: Epidemiological evidence for an association between habitual tea consumption and markers of chronic inflammation. Atherosclerosis 2006; 189 : 428-435.
72. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I: Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 2006; 296: 1255-1265.
73. Hakim IA, Alsaif MA, Alduwaihy M, Al-Ru-beaan K, Al-Nuaim AR, Al-Attas OS: Tea consumption and the prevalence of coronary heart disease in Saudi adults: results from a Saudi national study. Prev Med 2003; 36:64-70.
74. Arts IC, Hollman PC, Feskens EJ, Bueno de Mesquita HB, Kromhout D: Catechin intake might explain the inverse relation between tea consumption and ischemic heart disease: the Zutphen Elderly Study. Am J Clin Nutr 2001; 74:227-232.
75. Maron DJ, Lu GP, Cai NS, Wu ZG, Li YH, Chen H, Zhu JQ, Jin XJ, Wouters BC, Zhao J: Cholesterol-lowering effect of a theaflavin-enriched green tea extract: a randomized controlled trial. Arch Intern Med 2003; 163: 1448-1453.